1558-1559 / 2437
Adverse Events
Most common AE class
Skin and subcutaneous tissue disorders 25 (93%) patients
Most common AE terms
Pyrexia 14 (52%) patients
Fatigue 12 (44%) patients
Vomiting 12 (44%) patients
Headache 11 (41%) patients
Dose-limiting toxicity (1 event)
Grade 3 transient maculopapular rash at 4.5 mg/kg/day dose
Patient remains on study at reduced dose (3.75 mg/kg/day)